Abstract
Leukotriene A4 (LTA4) hydrolase which transforms LTA4 into the proinflammatory compound LTB4 has been identified in human epidermis. The purpose of this study was to investigate the potential role of this enzyme in psoriasis, in which LTB4 is present in biologically active concentrations. The concentration and activity of LTA4 hydrolase was determined in normal skin and in matched samples of involved and uninvolved psoriatic skin. The enzyme content was determined using an affinity-purified antibody. This antibody was also used for immunohistochemical staining of skin biopsies. Immunohistochemically LTA4 hydrolase was localized predominantly in the basal and spinous layers in normal skin and in involved and uninvolved psoriatic skin. The LTA4 hydrolase content varied between 2.8 and 3.1 μg enzyme/mg protein and was found to be similar in normal and psoriatic skin, involved as well as uninvolved. In contrast, the activity of the enzyme was decreased significantly in involved psoriatic skin (9.9±2.1 μg LTB4/mg enzyme per min) compared with matched uninvolved psoriatic skin (16.4±3.5 μg LTB4/mg enzyme per min), but was decreased only insignificantly compared with normal skin (12.4±1.8 μg LTB4/mg enzyme per min). It was found that the conversion of LTA4 to LTB4 results in inactivation of LTA4 hydrolase activity. This finding is compatible with the idea that the decreased LTA4 hydrolase activity in involved psoriatic skin reflects transcellular LTB4 formation in vivo. In peripheral lymphocytes the enzyme content was 1.3±0.3 μg enzyme/mg protein in normal lymphocytes and 1.4±0.3 μg enzyme/mg protein in psoriatic lymphocytes, which was significantly lower than in the skin. In contrast, the specific LTA4 hydrolase activities in normal and psoriatic lymphocytes (23.4±1.3 and 21.3±1.7 μg LTB4/mg enzyme per min) were significantly higher than in normal skin. These findings may indicate the existence of LTA4 hydrolase isoforms in human lymphocytes and human skin.
Similar content being viewed by others
References
Borgeat P, Samuelsson B (1979) Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc Natl Acad Sci USA 76:2148–2152
Borgeat P, Samuelsson B (1979) Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds. J Biol Chem 254:7865–7869
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Camp RDR, Coutts AA, Greaves MW, Kay AB, Walport MJ (1983) Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4. Br J Pharmacol 80:497–502
Camp RDR, Jones RR, Brain S, Woollard P, Greaves M (1984) Production of intraepidermal microabscesses by topical application of leukotriene B4. J Invest Dermatol 82:202–204
Claesson HE, Haeggström J (1988) Human endothelial cells stimulate leukotriene synthesis and convert granulocyte released leukotriene A4 into leukotrienes B4, C4, D4 and E4. Eur J Biochem 173:93–100
Czarnetzki BM, Rosenbach T (1986) Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-omega-oxidation products in vitro. Prostaglandins 31:851–858
Duell EA, Ellis CN, Voorhees JJ (1988) Determination of 5, 12 and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin. J Invest Dermatol 91:446–450
Edenius C, Heidvall K, Lindgren JÅ (1988) Novel transcellular interaction: conversion of granulocyte derived leukotriene A4 to cysteinyl-containing leukotrienes by human platelets. Eur J Biochem 178:81–86
Fogh K, Kiil J, Herlin T, Ternowitz T, Kragballe K (1987) Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions. Arch Dermatol Res 279:504–511
Fogh K, Herlin T, Kragballe K (1989) Eicosanoids in acute and chronic psoriatic lesions. Leukotrine B4, but not 12-hydroxy-eicosatetraenoic acid is present in biologically active concentrations in acute and guttate lesions. J Invest Dermatol 92:837–841
Ford-Hutchinson AW (1993) 5-lipoxygenase activation in psoriasis: a dead issue? Skin Pharmacol 6:292–297
Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH (1980) Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264–265
Fu JY, Haeggström JZ, Collins P, Meijer J, Rådmark O (1989) Leukotriene A4 hydrolase: analysis of some human tissues by radioimmunoassay. Biochim Biophys Acta 1006:121–126
Gimbrone MA Jr, Brock AF, Schafer AI (1984) Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells. J Clin Invest 74:1552–1555
Griffin KJ, Gierse J, Krivi G, Fitzpatrick FA (1992) Opioid peptides are substrates for the bifunctional enzyme LTA4 hydrolase/aminopeptidase. Prostaglandins 44:251–257
Haeggström J, Bergman T, Jörnvall H, Rådmark O (1988) Guinea-pig liver leukotriene A4 hydrolase. Purification, characterization and structural properties. Eur J Biochem 174:717–724
Haeggström J, Wetterholm A, Vallee BL, Samuelsson B (1990) Leukotriene A4 hydrolase: an epoxide hydrolase with peptidase activity. Biochem Biophys Res Commun 173:431–437
Ikai K, Okano H, Horiguchi Y, Sakamoto Y (1994) Leukotriene A4 hydrolase in human skin. J Invest Dermatol 102:253–257
Iversen L, Fogh K, Ziboh VA, Kristensen P, Schmedes A, Kragballe K (1993) Leukotriene B4 formation during human neutrophil keratinocyte interactions: evidence for transformation of leukotriene A4 by putative keratinocyte leukotriene A4 hydrolase. J Invest Dermatol 100:293–298
Iversen L, Kristensen P, Grøn B, Ziboh VA, Kragballe K (1994) Human epidermis transforms exogenous leukotriene A4 into peptide leukotrienes: possible role in transcellular metabolism. Arch Dermatol Res 286:261–267
Iversen L, Ziboh VA, Shimizu T, Ohishi N, Rådmark O, Wetterholm A, Kragballe K (1994) Identification and subcellular localization of leukotriene A4 hydrolase activity in human epidermis. J Dermatol Sci 7:191–201
Iversen L, Kristensen P, Nissen JB, Merrick WC, Kragballe K (1995) Purification and characterization of leukotriene A4 hydrolase from human epidermis. FEBS Lett 358:316–322
Izumi T, Shimizu T, Seyama Y, Ohishi N, Takaku F (1986) Tissue distribution of leukotriene A4 hydrolase activity in guinea pig. Biochem Biophys Res Commun 135:139–145
Jakobsson PJ, Odlander B, Claesson HE (1991) Effect of monocyte-lymphocyte interaction on the synthesis of leukotriene B4. Eur J Biochem 196:395–400
Jakschik BA, Kuo CG (1983) Characterization of leukotriene A4 and B4 biosynthesis. Prostaglandins 25:767–782
Kiil J, Kiil J, Søgaard H (1985) Surgical treatment of psoriasis. Lancet 2:16–18
Kragballe K, Ellegaard J, Herlin T (1980) Antibody-dependent monocyte-mediated cytotoxicity. The effects of adherence and removal of phagocytic cells, and of in vitro incubation. Scand J Haematol 24:405–409
Kragballe K, Desjarlais L, Voorhees JJ (1985) Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes. Br J Dermatol 113:43–52
Lammers AM, Van de Kerkhof PCM (1987) Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions. Br J Dermatol 117:541–544
Maycock AL, Anderson MS, DeSousa DM, Kuehl FA Jr (1982) Leukotriene A4: Preparation and enzymatic conversion in a cell-free system to leukotriene B4. J Biol Chem 257:13911–13914
McGee J, Fitzpatrick F (1985) Enzymatic hydration of leukotrien A4. Purification and characterization of a novel epoxide hydrolase from human erythrocytes. J Biol Chem 260:12832–12837
McGee JE, Fitzpatrick FA (1986) Erythrocyte-neutrophil interactions: formation of leukotriene B4 by transcellular biosynthesis. Proc Natl Acad Sci USA 83:1349–1353
Minami M, Ohishi N, Mutoh H, Izumi T, Bito H, Wada H, Seyama Y, Toh H, Shimizu T (1990) Leukotriene A4 hydrolase is a zinc-containing aminopeptidase. Biochem Biophys Res Commun 173:620–626
Munafo DA, Shindo K, Baker JR, Bigby TD (1994) Leukotriene A4 hydrolase in human bronchoalveolar lavage fluid. J Clin Invest 93:1042–1050
Nissen JB, Iversen L, Kragballe K (1995) Characterization of the aminopeptidase activity of epidermal leukotriene A4 hydrolase against the opioid dynorphin fragment 1–7. Br J Dermatol 133:742–749
Odlander B, Jakobsson PJ, Rosen A, Claesson HE (1988) Human B and T lymphocytes convert leukotriene A4 into leukotriene B4. Biochem Biophys Res Commun 153:203–208
Odlander B, Claesson HE, Bergman T, Rådmark O, Jörnvall H, Haeggström JZ (1991) Leukotriene A4 hydrolase in the human B-lymphocytic cell line Raji: indications of catalytically divergent forms of the enzyme. Arch Biochem Biophys 287:167–174
Ohishi N, Minami M, Kobayashi J, Seyama Y, Hata J, Yotsumoto H, Takaku F, Shimizu T (1990) Immunological quantitation and immunohistochemical localization of leukotriene A4 hydrolase in guinea pig tissues. J Biol Chem 265:7520–7525
Okano-Mitani H, Horiguchi Y, Ikai K, Imamura S (1993) Leukotriene A4 hydrolase in peripheral leukocytes and skin of patients with atopic dermatitis. J Dermatol Sci 6:94
Orning L, Jones DA, Fitzpatrick FA (1990) Mechanism-based inactivation of leukotriene A4 hydrolse during leukotriene B4 formation by human erythrocytes. J Biol Chem 265:14911–14916
Orning L, Krivi G, Fitzpatrick FA (1991) Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes. J Biol Chem 266:1375–1378
Orning L, Gierse J, Duffin K, Bild G, Krivi O, Fitzpatrick FA (1992) Mechanism-based inactivation of leukotriene A4 hydrolase/aminopeptidase by leukotriene A4. J Biol Chem 267: 22733–22739
Palmblad J, Malmsten CL, Uden AM, Rådmark O, Endstedt L, Samuelsson B (1981) Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood 58:658–661
Poubelle PE, Borgeat P, Rola-Pleszczynski M (1987) Assessment of leukotriene B4 synthesis in human lymphocytes by using high performance liquid chromatography and radioimmunoassay methods. J Immunol 139:1273–1277
Shak PK, Borchardt RT (1991) A comparison of peptidase activities and peptide metabolism in cultured mouse keratinocytes and neonatal mouse epidermis. Pharm Res 8:70–75
Sola J, Godessart N, Vila L, Puig L, Moragas JM de (1992) Epidermal cell-polymorphonuclear leukocyte cooperation in the formation of leukotriene B4 by transcellular biosynthesis. J Invest Dermatol 98:333–339
Soter NA, Lewis RA, Corey EJ, Austen F (1983) Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4 and LTB4) in human skin. J Invest Dermatol 80:115–119
Sun FF, McGuire JC (1984) Metabolism of arachidonic acid by human neutrophils. Characterization of the enzymatic reactions that lead to the synthesis of leukotriene B4. Biochim Biophys Acta 794:56–64
Takematsu H, Terui T, Tagami H (1986) Demonstration of leukotriene B4 in the scale extracts of psoriasis and inflammatory pustular dermatoses. Acta Derm Venereol (Stockh) 66:6–10
Wetterholm A, Haeggström JZ (1992) Leukotriene A4 hydrolase: an anion activated peptidase. Biochim Biophys Acta 1123:275–281
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iversen, L., Deleuran, B., Hoberg, A.M. et al. LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin. Arch Dermatol Res 288, 217–224 (1996). https://doi.org/10.1007/BF02530088
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02530088